SCHEMBL9915666

SCHEMBL9915666

CCn1c2ccc(C(=O)/C=C/c3ccccc3)cc2c2cc(C(=O)/C=C/c3ccccc3)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 9/20 0.54
MAOB P27338 5/20 0.52
TNFRSF1A P19438 3/20 0.52
MAOA P21397 2/20 0.52
MAPT P10636 6/20 0.51
LMNA P02545 3/20 0.51
PLIN1 O60240 1/20 0.51
BCHE P06276 1/20 0.51
ACHE P22303 1/20 0.51
RECQL P46063 1/20 0.51
PLIN5 Q00G26 1/20 0.51
ABHD5 Q8WTS1 1/20 0.51
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
HSPD1 P10809 2/20 0.50
HSPE1 P61604 2/20 0.50
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALDH2 P05091 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12012974 0.90 CNR2 (0.47) CYP1B1MAOBTNFRSF1AMAOAMAPT
Chalcone SCHEMBL27869790 0.85 MAPT (0.61) CYP1B1MAOBTNFRSF1AMAOAMAPT
SCHEMBL29003694 0.85 F3 (0.55) CYP1B1MAOBTNFRSF1AMAOAMAPT
SCHEMBL30274993 0.85 F3 (0.55) CYP1B1MAOBTNFRSF1AMAOAMAPT
SCHEMBL9915670 0.85 MAPT (0.56) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL25191392 0.83 ALDH1A1 (0.55) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL30384006 0.83 ALDH1A1 (0.55) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL28639419 0.82 MAPT (0.47) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL30367351 0.82 MAPT (0.47) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL7594006 0.81 ABCG2 (0.59) TNFRSF1AMAPTLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164826-B1 DENDRITIC PHOTOACTIVE COMPOUND COMPRISING OXIME ESTER AND METHOD FOR PREPARING THE SAME LG CHEMICAL LTD (KR) 2013-04-03 EP disclosed
US-8198462-B2 Dendritic photoactive compound comprising oxime ester and method for preparing the same LG CHEM, LTD. (KR) 2012-06-12 US disclosed
US-8198462-B2 Dendritic photoactive compound comprising oxime ester and method for preparing the same LG CHEM, LTD. (KR) 2012-06-12 US disclosed
US-20100145068-A1 Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same LG CHEM, LTD. (KR) 2010-06-10 US disclosed
US-20100145068-A1 Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same LG CHEM, LTD. (KR) 2010-06-10 US disclosed
WO-2009011538-A2 DENDRITIC PHOTOACTIVE COMPOUND COMPRISING OXIME ESTER AND METHOD FOR PREPARING THE SAME LG CHEM, LTD. (KR) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145068-A1 Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same PPOX, OXER1, TLR7 CYP1B1 2436/4885MAOB 260/4885TNFRSF1A 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.